[1] JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell , 1992, 69(6): 905-914.
[2] X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature , 1998, 393(6683): 386-389.
[3] DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci US A , 2007, 104(49): 19416-19421.
[4] X, Bao X, Zhang J, Zhao Y, Cao G, Pan H, Wei L, Wu X. Molecular characteristics of Chinese patients with Rett syndrome. Eur J Med Genet , 2012, 55(12): 677-681.
[5] RS, Lane JB, Childers J, Skinner SA, Annese F, Barrish JO, Glaze DG, Macleod P, Percy AK. Longevity in Rett syndrome: analysis of the North American Database. J Pediatr , 2010, 156(1): 135-138.
[6] JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, Leonard H, Bailey ME, Schanen NC, Zappella M, Renieri A, Huppke P, Percy AK. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol , 2010, 68(6): 944-950.
[7] R, Parrini E. Epilepsy in Rett syndrome, and CDKL5-and FOXG1-gene-related encephalopathies. Epilepsia , 2012, 53(12): 2067-2078.
[8] MR, Pan H, Bao XH, Zhang YZ, Wu XR. MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome. J Hum Genet , 2007, 52(1): 38-47.
[9] T, Chelly J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet , 2006, 7(6): 415-426.
[10] M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron , 2007, 56(3): 422-437.
[11] E, Longo I, Ottimo F, Speciale C, Sampieri K, Katzaki E, Artuso R, Mencarelli MA, D'Ambrogio T, Vonella G, Zappella M, Hayek G, Battaglia A, Mari F, Renieri A, Ariani F. MECP2 deletions and genotype-phenotype correlation in Rett syndrome. Am J Med Genet A , 2007, 143A(23): 2775-2784.
[12] L, De Filippis B, Laviola G. Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav Pharmacol , 2008, 19(5-6): 501-517.
[13] P, Ogier M, Brooks-Harris G, Schmid DA, Katz DM, Nelson SB. Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J Neurosci , 2009, 29(39): 12187-12195.
[14] L, Shepherd GM. Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in a mutant mouse model of Rett syndrome. Neurobiol Dis , 2010, 38(2): 281-287.
[15] G, Hablitz JJ, Pozzo-Miller L. Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J Neurophysiol , 2011, 105(4): 1768-1784.
[16] B, Soto CJ, Saez M, Abrams A, Walz K, Young JI. Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. Eur J Hum Genet , 2012, 20(1): 69-76.
[17] JM, Kim YH, Arnold AP, Schanen NC. Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J Comp Neurol , 2007, 501(4): 526-542.
[18] PJ, Illingworth RS, Webb S, Kerr AR, James KD, Turner DJ, Andrews R, Bird AP. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell , 2010, 37(4): 457-468.
[19] N, Lioy DT, Grunseich C, Mandel G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci , 2009, 12(3): 311-317.
[20] I, Jin LW. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci , 2010, 30(15): 5346-5356.
[21] RP, Nikitina T, Horowitz-Scherer RA, Gierasch LM, Uversky VN, Hite K, Hansen JC, Woodcock CL. Unique physical properties and interactions of the domains of
